Myristicin from parsley leaf oil
SIGMA/M9411 - ≥85% (HPLC), oil
Synonym: 4-
CAS Number: 607-91-0
Empirical Formula (Hill Notation): C11H12O3
Molecular Weight: 192.21
EC Number: 210-146-9
MDL Number: MFCD00133549
Linear Formula: C11H12O3
Product Type: Chemical
| application(s) | metabolomics vitamins, nutraceuticals, and natural products |
| assay | ≥85% (HPLC) |
| color | clear light yellow |
| form | oil |
| InChI | 1S/C11H12O3/c1-3-4-8-5-9( |
| InChI key | BNWJOHGLIBDBOB-UHFFFAOYSA |
| Quality Level | 200  |
| SMILES string | COc1cc(CC=C)cc2OCOc12 |
| storage temp. | 2-8°C |
| Application: | Myristicin from parsley leaf oil has been used to study competitive and uncompetitive inhibition of ACP (acid phosphatase) and ALP (alkaline phosphatase). |
| Biochem/physiol Actions: | Myristicin induces the expression of glutathione S-transferase and cytochrome P450 (Cyp1a-1) in liver cells. May enhance detoxification of carcinogenic substances. |
| General description: | Myristicin, a phenylpropene, is an essential oil component. It has anticholinergic and psychotropic activities. Myristicin blocks cytochrome P450 monooxygenases, which detoxifies furanocoumarins. It functions as a serotonin receptor agonist and hallucinogenic agent. Myristicin stimulates glutathione S-transferase activity and might function as a chemopreventive agent. It acts as a precursor for the metabolite 3,4- methylenedioxymethampheta |
| Packaging: | 100 mg in glass bottle |
| Symbol |    GHS07,GHS08,GHS09 |
| Signal word | Warning |
| Hazard statements | H302 - H361f - H411 |
| Precautionary statements | P202 - P264 - P270 - P273 - P301 + P312 - P308 + P313 |
| Risk Statements | 52/53 |
| Safety Statements | 61 |
| RIDADR | UN 3082 9 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥85% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352205 |